Sodium Polystyrene Sulfonate Powder, For Suspension
Product Images NDC 42806-013

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sodium Polystyrene Sulfonate (NDC 42806-013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Epic Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

L:\labeling Department\anda\sodium Polystyrene Sulfonate_sz- Done\epic\spl\archive\version 7 Sodium Polystyrene\spl\14 (14)

L:\labeling Department\anda\sodium Polystyrene Sulfonate_sz- Done\epic\spl\archive\version 7 Sodium Polystyrene\spl\14 (14)
This is a description of a medication with dosage instructions, manufacturer information, and guidelines for storage. The medication is a powder for suspension called Sodium Polystyrene Sulfonate and is prescribed for adults with a recommended dose of 15 g taken one to four times daily with water. It is important to monitor serum potassium levels and the sodium content in each dose. The medication should be freshly prepared and not stored beyond 24 hours. It should be dispensed in light-resistant containers and stored at room temperature (20°C to 25°C).*
FDA Label Image

Image 01

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.